Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013 (2013), Article ID 865159, 10 pages
http://dx.doi.org/10.1155/2013/865159
Research Article

Blockade of 4-1BB and 4-1BBL Interaction Reduces Obesity-Induced Skeletal Muscle Inflammation

1Department of Food Science and Nutrition, University of Ulsan, Ulsan 680-749, Republic of Korea
2Department of Biological Science, University of Ulsan, Ulsan 680-749, Republic of Korea
3Graduate School of Agriculture, Kyoto University, Uji, Kyoto 611-0011, Japan
4Department of Food and Nutrition, Yonsei University, Seoul 120-749, Republic of Korea
5Department of Food Science and Nutrition and Research Institute for Bioscience & Biotechnology, Hallym University, Chuncheon 200-702, Republic of Korea

Received 18 June 2013; Revised 12 November 2013; Accepted 20 November 2013

Academic Editor: Jonathan Peake

Copyright © 2013 Ngoc Hoan Le et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. N. Lumeng and A. R. Saltiel, “Inflammatory links between obesity and metabolic disease,” Journal of Clinical Investigation, vol. 121, no. 6, pp. 2111–2117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Valerio, A. Cardile, V. Cozzi et al., “TNF-α downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents,” Journal of Clinical Investigation, vol. 116, no. 10, pp. 2791–2798, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Tang, P. D. Wagner, and E. C. Breen, “TNF-α-mediated reduction in PGC-1α may impair skeletal muscle function after cigarette smoke exposure,” Journal of Cellular Physiology, vol. 222, no. 2, pp. 320–327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Varma, A. Yao-Borengasser, N. Rasouli et al., “Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action,” The American Journal of Physiology, vol. 298, pp. E988–E998, 2009. View at Google Scholar · View at Scopus
  6. D. Patsouris, P.-P. Li, D. Thapar, J. Chapman, J. M. Olefsky, and J. G. Neels, “Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals,” Cell Metabolism, vol. 8, no. 4, pp. 301–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. R. Koves, J. R. Ussher, R. C. Noland et al., “Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance,” Cell Metabolism, vol. 7, no. 1, pp. 45–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Du, X. Yan, J. F. Tong, J. Zhao, and M. J. Zhu, “Maternal obesity, inflammation, and fetal skeletal muscle development,” Biology of Reproduction, vol. 82, no. 1, pp. 4–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Hurtado, S. H. Kim, K. E. Pollok, Z. H. Lee, and B. S. Kwon, “Potential role of 4-1BB in T cell activation: comparison with the costimulatory molecule CD28,” Journal of Immunology, vol. 155, no. 7, pp. 3360–3367, 1995. View at Google Scholar · View at Scopus
  10. D.-H. Kim, W.-S. Chang, Y.-S. Lee et al., “4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation,” Journal of Immunology, vol. 180, no. 4, pp. 2062–2068, 2008. View at Google Scholar · View at Scopus
  11. D. S. Vinay and B. S. Kwon, “Role of 4-1BB in immune responses,” Seminars in Immunology, vol. 10, no. 6, pp. 481–489, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Takahashi, R. S. Mittler, and A. T. Vella, “Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal,” Journal of Immunology, vol. 162, no. 9, pp. 5037–5040, 1999. View at Google Scholar · View at Scopus
  13. C. T. Y. Cheung, T. A. Deisher, H. Luo et al., “Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis,” Laboratory Investigation, vol. 87, no. 7, pp. 651–661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. J. Jeon, J.-H. Choi, I.-H. Jung et al., “CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice,” Circulation, vol. 121, no. 9, pp. 1124–1133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Q.-T. Nguyen, S.-A. Ju, S.-M. Park et al., “Blockade of CD137 signaling counteracts polymicrobial sepsis induced by cecal ligation and puncture,” Infection and Immunity, vol. 77, no. 9, pp. 3932–3938, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C.-S. Kim, J. G. Kim, B.-J. Lee et al., “Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders,” Diabetes, vol. 60, no. 12, pp. 3159–3168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. T. H. Tu, C. S. Kim, T. Goto, T. Kawada, B. S. Kim, and R. Yu, “4-1BB/4-1BBL interaction promotes obesity-induced adipose inflammation by triggering bidirectional inflammatory signaling in adipocytes/macrophages,” Mediators of Inflammation, vol. 2012, Article ID 972629, 10 pages, 2012. View at Publisher · View at Google Scholar
  18. B. S. Kwon, J. C. Hurtado, Z. H. Lee et al., “Immune responses in 4-1BB (CD137)-deficient mice,” Journal of Immunology, vol. 168, no. 11, pp. 5483–5490, 2002. View at Google Scholar · View at Scopus
  19. W. W. Shuford, K. Klussman, D. D. Tritchler et al., “4-1BB costimulatory signals preferentially induce CD8+T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses,” Journal of Experimental Medicine, vol. 186, no. 1, pp. 47–55, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. T. A. Rando and H. M. Blau, “Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy,” Journal of Cell Biology, vol. 125, no. 6, pp. 1275–1287, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Jové, A. Planavila, R. M. Sánchez, M. Merlos, J. C. Laguna, and M. Vázquez-Carrera, “Palmitate induces tumor necrosis factor-α expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-κB activation,” Endocrinology, vol. 147, no. 1, pp. 552–561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Schenk, M. Saberi, and J. M. Olefsky, “Insulin sensitivity: modulation by nutrients and inflammation,” Journal of Clinical Investigation, vol. 118, no. 9, pp. 2992–3002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. S. Olofsson, L. Å. Söderström, D. Wågsäter et al., “CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice,” Circulation, vol. 117, no. 10, pp. 1292–1301, 2008. View at Google Scholar
  24. T. Haga, J.-I. Suzuki, H. Kosuge et al., “Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway,” Journal of Molecular and Cellular Cardiology, vol. 46, no. 5, pp. 719–727, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Fiocchi, “Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions,” The American Journal of Physiology, vol. 273, no. 4, pp. G769–G775, 1997. View at Google Scholar · View at Scopus
  26. M. I. Frisard, R. P. McMillan, J. Marchand et al., “Toll-like receptor 4 modulates skeletal muscle substrate metabolism,” The American Journal of Physiology, vol. 298, no. 5, pp. E988–E998, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. Y.-P. Li, Y. Chen, J. John et al., “TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle,” The FASEB Journal, vol. 19, no. 3, pp. 362–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Kwon, “CD137-CD137 ligand interactions in inflammation,” Immune Network, vol. 9, no. 3, pp. 84–89, 2009. View at Google Scholar
  29. D. Drenkard, F. M. Becke, J. Langstein et al., “CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity,” The FASEB Journal, vol. 21, no. 2, pp. 456–463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Schwarz, “Biological activities of reverse signal transduction through CD137 ligand,” Journal of Leukocyte Biology, vol. 77, no. 3, pp. 281–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Lu, D. Huang, R. M. Ransohoff, and L. Zhou, “Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair,” The FASEB Journal, vol. 25, no. 10, pp. 3344–3355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Kanda, S. Tateya, Y. Tamori et al., “MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity,” Journal of Clinical Investigation, vol. 116, no. 6, pp. 1494–1505, 2006. View at Publisher · View at Google Scholar · View at Scopus